Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Submitted by
admin
on September 30, 2013 - 4:29pm
Source:
Motley Fool
News Tags:
Alzheimer's disease
LY2886721
Eli Lilly
MK-8931
Merck
bapineuzumab
JNJ
solanezumab
Gammagard
Baxter International
Headline:
Which Alzheimer's Fighter Will Benefit From a Boost in Federal Funding?
Do Not Allow Advertisers to Use My Personal information